Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer
Titel:
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer
Auteur:
Peters, Solange Shaw, Alice T. Besse, Benjamin Felip, Enriqueta Solomon, Benjamin J. Soo, Ross A. Bearz, Alessandra Gadgeel, Shirish M. Lin, Chia-Chi Kao, Steven Seto, Takashi Masters, Elizabeth T. Abbattista, Antonello Clancy, Jill S. Thurm, Holger Reisman, Arlene Peltz, Gerson Ross Camidge, D.